Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of this study was to explore the effect of bromocriptine on the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yiqun, Ponandai-srinivasan, Sakthivignesh, Frisendahl, Caroline, Andersson, Johanna K., Pavone, Dora, Stewart, Elizabeth A., Lalitkumar, Parameswaran Grace Luther, Korsching, Eberhard, Bogavarappu, Nageswara Rao, Gemzell-Danielsson, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034369/
https://www.ncbi.nlm.nih.gov/pubmed/36967761
http://dx.doi.org/10.3389/fendo.2023.1026168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034369/
https://www.ncbi.nlm.nih.gov/pubmed/36967761
http://dx.doi.org/10.3389/fendo.2023.1026168

Ejemplares similares